시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 비침습 콜레스테롤 측정기 시장 보고서(2025년)
Non-Invasive Cholesterol Reader Global Market Report 2025
상품코드 : 1877829
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

비침습 콜레스테롤 측정기 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 11억 3,000만 달러로 평가되었고, 2025년에는 13억 달러에 이르고, CAGR 15.5%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장은 심혈관 질환 증가 추세, 콜레스테롤 모니터링에 대한 의식 향상, 예방 의료 솔루션에 대한 수요 증가, 정부 주도 의료 시책의 급증, 신흥국의 의료 인프라 확충 및 재택 건강 모니터링 장비의 보급 확대에 기인할 것으로 예측됩니다.

비침습 콜레스테롤 측정기 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 22억 9,000만 달러에 이르고, CAGR은 15.2%를 나타낼 전망입니다. 예측기간중의 성장 요인으로는 질병의 조기 발견·관리에 대한 주목의 높아짐, 지질이상증 위험이 높은 고령 인구 증가, 선진국·개발도상국 양쪽에 있어서의 의료비 지출의 확대, 생활 습관병 관련의 건강 문제의 급증, 진단 스크리닝의 보험 적용 범위 확대, 비침습적 진단 솔루션에 대한 환자의 선호 증가 등을 들 수 있습니다. 이 기간에 예상되는 주요 동향으로는 광학 센싱 기술의 진보, 웨어러블 생체 센서 통합의 진전, POC(Point of Care) 진단 플랫폼의 혁신, 실시간 콜레스테롤 모니터링 시스템의 개발, 비침습적 지질 프로파일링 기법의 연구 개발, 개별화 콜레스테롤 관리를 위한 데이터 분석의 개선 등이 있습니다.

향후 수년간 비침습 콜레스테롤 측정기 시장의 성장을 이끌 것으로 예상되는 것은 심혈관 질환의 유병률 상승입니다. 관상동맥질환, 뇌졸중, 심부전 등의 심혈관질환은 고령화나 운동부족의 생활습관에 의해 심장·혈관합병증의 리스크가 높아짐으로써 점점 일반적으로 되고 있습니다. 비침습 콜레스테롤 측정기는 혈액 샘플을 필요로 하지 않고 신속한 콜레스테롤 측정을 가능하게 하고 심장마비와 뇌졸중 위험을 줄이는 시기 적절한 개입을 지원함으로써 조기 발견에 중요한 역할을 합니다. 예를 들어, 미국 질병 예방관리센터(CDC)의 보고에 따르면 2023년 심혈관 질환으로 인해 919,032명이 사망했고, 전체 사망자의 약 3분의 1을 차지했습니다. 따라서 심혈관 질환 증가 추세는 비침습성 콜레스테롤 계측기 시장의 확대에 크게 기여하고 있습니다.

의료비 지출 증가는 비침습 콜레스테롤 측정기 시장의 성장을 가속할 것으로 예측됩니다. 의료비 지출이란 국민의 건강 증진을 목적으로 하는 의료 서비스, 치료, 건강 관련 제품에 대한 총 지출을 말합니다. 의료비의 꾸준한 증가는 지속적인 관리와 관리가 필요한 만성 질환의 부담 증가가 주요 요인입니다. 의료 분야에 대한 투자 확대는 콜레스테롤의 조기 모니터링을 가능하게 하고 침습적 치료와 고액의 통원에 대한 의존도를 줄이는 비침습적 진단 기술의 개발과 보급을 촉진합니다. 예를 들어 영국 정부 기관인 국가 통계국(ONS)에 따르면 2024년 영국의 공적 의료 지출은 3,460억 달러(2,580억 파운드)에 이르렀으며, 2023년 대비 실질 2.5% 증가했습니다. 따라서 의료비 지출 증가는 비침습 콜레스테롤 측정기 수요 증가에 있어 매우 중요한 역할을 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A non-invasive cholesterol reader is a medical device or diagnostic tool used to measure cholesterol levels in the body without the need for blood samples or needles. These devices commonly utilize technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external methods.

The primary product types of non-invasive cholesterol readers include wearable devices, handheld devices, and tabletop devices. Wearable devices are small, body-mounted instruments such as patches, bands, or wristbands that collect physiological data continuously or at regular intervals with minimal discomfort. These devices operate using technologies such as optical, ultrasound, electrical, and others. They are distributed through both online and offline channels and are used across various applications, including home care, hospitals and clinics, diagnostic centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The non-invasive cholesterol reader market research report is one of a series of new reports from The Business Research Company that provides non-invasive cholesterol reader market statistics, including non-invasive cholesterol reader industry global market size, regional shares, competitors with a non-invasive cholesterol reader market share, detailed non-invasive cholesterol reader market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. This non-invasive cholesterol reader market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-invasive cholesterol reader market size has grown rapidly in recent years. It will grow from $1.13 billion in 2024 to $1.30 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. Growth during the historic period can be attributed to the rising prevalence of cardiovascular diseases, increasing awareness of cholesterol monitoring, growing demand for preventive healthcare solutions, surge in government healthcare initiatives, expansion of healthcare infrastructure in emerging economies, and the increasing adoption of home-based health monitoring devices.

The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. Growth during the forecast period can be attributed to the increasing focus on early disease detection and management, rising geriatric population prone to lipid disorders, growing healthcare expenditure in both developed and developing countries, surge in lifestyle-related health issues, expansion of insurance coverage for diagnostic screenings, and increasing patient preference for non-invasive diagnostic solutions. Key trends expected during this period include technological progress in optical sensing techniques, advancements in wearable biosensor integration, innovations in point-of-care diagnostic platforms, developments in real-time cholesterol monitoring systems, research and development in non-invasive lipid profiling methods, and improvements in data analytics for personalized cholesterol management.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the non-invasive cholesterol reader market in the coming years. Cardiovascular diseases, including coronary artery disease, stroke, and heart failure, are becoming increasingly common due to aging populations and sedentary lifestyles that elevate the risk of heart and vascular complications. Non-invasive cholesterol readers play a crucial role in early detection by enabling quick cholesterol measurements without the need for blood samples, supporting timely interventions to reduce the risk of heart attacks and strokes. For example, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, cardiovascular diseases caused 919,032 deaths in 2023, accounting for nearly one-third of all deaths. Hence, the growing incidence of cardiovascular diseases is contributing significantly to the expansion of the non-invasive cholesterol reader market.

The rise in healthcare expenditure is expected to boost the growth of the non-invasive cholesterol reader market. Healthcare expenditure encompasses total spending on medical services, treatments, and health-related goods aimed at improving population health. The steady increase in healthcare spending is primarily driven by the growing burden of chronic diseases, which demand ongoing care and management. Higher investment in healthcare facilitates the development and adoption of non-invasive diagnostic technologies that enable early cholesterol monitoring and reduce dependence on invasive procedures and costly hospital visits. For instance, according to the Office for National Statistics (ONS), a U.K.-based government agency, public healthcare spending in the United Kingdom reached $346 billion (£258 billion) in 2024, marking a 2.5% increase in real terms compared to 2023. Therefore, the rising healthcare expenditure is playing a pivotal role in driving demand for non-invasive cholesterol readers.

In August 2024, the National University of Singapore (NUS) collaborated with the Agency for Science, Technology and Research (ASTAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels through the skin. The partnership aims to design and commercialize a wearable hydrogel-based sensor for continuous, real-time, and non-invasive monitoring of biomarkers such as cholesterol and glucose on dry skin. This innovation is expected to enhance early disease detection, chronic disease management, and remote health monitoring. ASTAR, a Singapore-based public research agency focused on economic-driven innovation, is actively contributing to the advancement of non-invasive cholesterol reader technologies.

Major players in the non-invasive cholesterol reader market are Syntec Optics, Philips Healthcare, Hoya Corporation, Revvity Inc., Canon Medical Systems Corporation, Agency for Science, Technology and Research (A*STAR), Jenoptik AG, Leica Microsystems GmbH, MLOptic Corp., Perimeter Medical Imaging AI Inc., PreVu Inc., Hamamatsu Photonics K.K., SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., Modulim Inc., Meyer Instruments Inc., DermaSensor Inc., MediBioSense Health Care, Medphab, and Syrma Johari MedTech Limited.

North America was the largest region in the non-invasive cholesterol reader market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in non-invasive cholesterol reader report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-invasive cholesterol reader market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Invasive Cholesterol Reader Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-invasive cholesterol reader market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for non-invasive cholesterol reader ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-invasive cholesterol reader market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Non-Invasive Cholesterol Reader Market Characteristics

3. Non-Invasive Cholesterol Reader Market Trends And Strategies

4. Non-Invasive Cholesterol Reader Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non-Invasive Cholesterol Reader Growth Analysis And Strategic Analysis Framework

6. Non-Invasive Cholesterol Reader Market Segmentation

7. Non-Invasive Cholesterol Reader Market Regional And Country Analysis

8. Asia-Pacific Non-Invasive Cholesterol Reader Market

9. China Non-Invasive Cholesterol Reader Market

10. India Non-Invasive Cholesterol Reader Market

11. Japan Non-Invasive Cholesterol Reader Market

12. Australia Non-Invasive Cholesterol Reader Market

13. Indonesia Non-Invasive Cholesterol Reader Market

14. South Korea Non-Invasive Cholesterol Reader Market

15. Western Europe Non-Invasive Cholesterol Reader Market

16. UK Non-Invasive Cholesterol Reader Market

17. Germany Non-Invasive Cholesterol Reader Market

18. France Non-Invasive Cholesterol Reader Market

19. Italy Non-Invasive Cholesterol Reader Market

20. Spain Non-Invasive Cholesterol Reader Market

21. Eastern Europe Non-Invasive Cholesterol Reader Market

22. Russia Non-Invasive Cholesterol Reader Market

23. North America Non-Invasive Cholesterol Reader Market

24. USA Non-Invasive Cholesterol Reader Market

25. Canada Non-Invasive Cholesterol Reader Market

26. South America Non-Invasive Cholesterol Reader Market

27. Brazil Non-Invasive Cholesterol Reader Market

28. Middle East Non-Invasive Cholesterol Reader Market

29. Africa Non-Invasive Cholesterol Reader Market

30. Non-Invasive Cholesterol Reader Market Competitive Landscape And Company Profiles

31. Non-Invasive Cholesterol Reader Market Other Major And Innovative Companies

32. Global Non-Invasive Cholesterol Reader Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Invasive Cholesterol Reader Market

34. Recent Developments In The Non-Invasive Cholesterol Reader Market

35. Non-Invasive Cholesterol Reader Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기